SYRE
Spyre Therapeutics Inc.
$51.77
$0.00(0.00%)
57
Overall
60
Value
91
Tech
21
Quality
Market Cap
$1.65B
Volume
585.55K
52W Range
$10.91 - $51.06
Target Price
$60.79
EPS Estimates Overview
| Current Quarter | $-0.67 | Next Quarter | $-0.7 |
| Current Year | $-2.8 | Next Year | $-2.77 |
| QoQ Growth | -4.5% | YoY Growth | +1.1% |
| 3Y EPS CAGR | +0.0% | Target Price | $60.79 |
| Consensus | Buy | Upside | +17.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $51.77 | 0% | 585.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |